Swedish immuno-oncology play Immunicum AB has appointed Carlos de Sousa as its new CEO. Most recently, de...
Up to date
Appointments
Immunotherapy maker TxCell SA has appointed gene therapy expert Olivier Danos to its newly founded Scientific...
Six months ago, Andrew Witty, long-time CEO of Britains largest drug maker GlaxoSmithKline, announced he would...
German molecular diagnostics specialist GNA Biosolutions GmbH has appointed Frank Krieg-Schneider as its...
Swedish Gyros Protein Technologies AB, which was formed in spring by merging nanoliter-scale immunoassay...
Galvani Bioelectronics, the developer of bioelectronic medicines launched by GlaxoSmithKline and Alphabet’s...
Share
